Pluristem Therapeutics Inc (PSTI)

[skitahoe]

One other thought, if treatment is early, isn't it very possible that far less of our drug will be all that's needed to be effective. If that's the case, the cost for treating earlier will come down. As I see it, PLX-PAD is essentially made up of multi-millions of miracle workers, it shouldn't take as many of them if it's given earlier in the treatment protocol. Perhaps you still want to distribute it to many places, but the amount in each point could be substantially reduced.

I'll leave it up to the experts to find out what's true, and what's not in what I'm suggesting. Clearly, substantial clinical trials are needed to optimize how treatment is done, however, once approved for the sickest to use, I'm sure it will be used off label for many who aren't as sick. My point is that optimum use for those who aren't on ventilators may show that far less is needed if intervention is early. Who knows, we might just find that even the tiniest dose may be the answer to quickening the cure of the common cold.

Gary